Delta Variant Delays UK COVID-19 Reopening Plan


California has administered more than 40 million doses of the COVID-19 vaccine.

This article was originally published in ContagionLive.

As the COVID-19 Delta variant, which originated in India, sweeps through the UK, Prime Minister Boris Johnson announced a delay in the country’s reopening.

England was posed to remove all of the remaining restrictions on June 21, but as cases are on the rise, public health experts are warning that the new variant may pose a significant risk.

The decision comes out of an abundance of caution, due to the Delta variant having been reported to be more transmissible than the strain that swept across the country over the winter.

In Thailand, delays in a mass inoculation effort continue amid one of the worst outbreaks of COVID-19 the country has seen since the start of the pandemic.

Health officials had initially planned to have 70% of the population vaccinated by the end of the year, but a week after the program was supposed to begin, many people have had their appointments cancelled. As of Monday, only about 3% of Thailand has been fully vaccinated.

In Italy, the government recently announced that it was restricting the use of the AstraZeneca vaccine to only those people over the age of 60. The decision comes after an 18 year old passed away after receiving the shot in late May.


892.77 million

62.03 per 100

United States

309.32 million

92.49 per 100


249.43 million

18.07 per 100


78.13 million

36.76 per 100

United Kingdom

71.34 million

105.09 per 100


60.11 million

71.74 per 100


44.13 million

65.31 per 100


42.25 million

69.87 per 100


32.83 million

22.5 per 100


31.73 million

11.6 per 100

Data Table per Our World in Data (June 13, 2021, 12 AM EST)

In the United States, California will fully reopen its economy and take away most social distancing rules on Tuesday, as the state has now administered 40 million doses of COVID-19 vaccines.



102.25 per 100



83.54 per 100

New York


106.00 per 100



91.80 per 100



103.64 per 100



96.15 per 100



87.73 per 100

New Jersey


108.32 per 100



90.51 per 100



102.81 per 100

Data Table per CDC COVID-19 Tracker (June 13, 2021, 6 AM EST)

For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:

Novavax COVID-19 Vaccine Provides 90% Efficacy, Will Submit for Regulation

Discussing Nanoparticle and Adenovirus Vaccine Platforms

FDA: Throw Out 60 Million COVID-19 Vaccine Doses

Related Videos
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Mikkael Sekeres, MD:
© 2024 MJH Life Sciences

All rights reserved.